ATE367810T1 - Zusammensetzung zur prävention von osteoporose bestehend aus einer kombination aus isoflavonen und polyungesättigten fettsäuren - Google Patents

Zusammensetzung zur prävention von osteoporose bestehend aus einer kombination aus isoflavonen und polyungesättigten fettsäuren

Info

Publication number
ATE367810T1
ATE367810T1 AT02726156T AT02726156T ATE367810T1 AT E367810 T1 ATE367810 T1 AT E367810T1 AT 02726156 T AT02726156 T AT 02726156T AT 02726156 T AT02726156 T AT 02726156T AT E367810 T1 ATE367810 T1 AT E367810T1
Authority
AT
Austria
Prior art keywords
vitamin
polyunsaturated fatty
isoflavones
prevention
composition
Prior art date
Application number
AT02726156T
Other languages
English (en)
Inventor
Stephanie Krammer
Christoph Riegger
Manfred Schlachter
Peter Weber
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE367810T1 publication Critical patent/ATE367810T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Botany (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT02726156T 2001-03-15 2002-03-11 Zusammensetzung zur prävention von osteoporose bestehend aus einer kombination aus isoflavonen und polyungesättigten fettsäuren ATE367810T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01106520 2001-03-15

Publications (1)

Publication Number Publication Date
ATE367810T1 true ATE367810T1 (de) 2007-08-15

Family

ID=8176795

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02726156T ATE367810T1 (de) 2001-03-15 2002-03-11 Zusammensetzung zur prävention von osteoporose bestehend aus einer kombination aus isoflavonen und polyungesättigten fettsäuren

Country Status (12)

Country Link
US (1) US7635692B2 (de)
EP (3) EP1370257B1 (de)
JP (1) JP4646491B2 (de)
KR (1) KR100875800B1 (de)
CN (1) CN100389765C (de)
AT (1) ATE367810T1 (de)
BR (1) BRPI0208103B8 (de)
CA (1) CA2440261C (de)
DE (1) DE60221367T2 (de)
ES (1) ES2289097T3 (de)
MX (1) MXPA03008137A (de)
WO (1) WO2002074308A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005524638A (ja) * 2002-02-15 2005-08-18 エヌ・ヴイ・ヌートリシア 骨粗しょう症及び肥満処置用医薬の製造におけるゲニステインの使用及びビタミンｄ及びｋと組合わせてゲニステインを含有する組成物
ITMI20022723A1 (it) * 2002-12-20 2004-06-21 Marfarma S R L Ora Marfarma Holding Spa Composizioni per il trattamento della sindrome post-menopausa.
CA2560595C (en) * 2004-03-29 2013-01-22 Wyeth Multi-vitamin and mineral nutritional supplements
CN100351248C (zh) * 2004-07-05 2007-11-28 南京大学 染料木素衍生物及其制法和用途
US7601370B2 (en) 2004-07-28 2009-10-13 Abbott Laboratories Method for controlling body weight in estrogen-insufficient women
JP5566008B2 (ja) * 2005-02-15 2014-08-06 ディーエスエム アイピー アセッツ ビー．ブイ． 多糖類含有組成物
WO2006088418A1 (en) * 2005-02-18 2006-08-24 Core Competence Sweden Ab A composition comprising a powder containing microencapsulated polyunsaturated long-chain esterified fatty acids distributed in an effervescent base
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
US20090221690A1 (en) 2006-02-28 2009-09-03 Council Of Scientific And Industrial Research Pharmaceutical Composition for the Prevention/Treatment of Bone Disorders and a Process for the Preparation Thereof
JP5227195B2 (ja) 2006-02-28 2013-07-03 ネステク ソシエテ アノニム 骨成長の誘発及び骨損失の抑制のための組成物及び方法
ES2391305T3 (es) 2006-04-12 2012-11-23 Unilever N.V. Composición oral que comprende un ácido graso poliinsaturado y ácido salicílico para obtener un efecto antiinflamatorio en la piel
EP2004161B8 (de) * 2006-04-12 2013-04-17 Unilever PLC Orale zusammensetzung mit dha und genistein zur verbesserung der hauteigenschaften
PL2189155T3 (pl) 2006-04-12 2016-07-29 Unilever Nv Doustna kompozycja o przeciwstarzeniowym działaniu na skórę
EP2015644A1 (de) * 2006-05-10 2009-01-21 DSMIP Assets B.V. Tierfutterzusammensetzung, die genistein und mehrfach ungesättigte fettsäuren enthält
US20070298079A1 (en) * 2006-06-26 2007-12-27 Tropicana Products, Inc. Food fortified with omega-3 fatty acids
JP5827784B2 (ja) * 2006-07-14 2015-12-02 ナットファルマ エーエスエー ビタミンｋ２を含む医薬及び栄養補助製品
EP1897530A1 (de) * 2006-09-08 2008-03-12 DSMIP Assets B.V. Hautpflegezusammensetzung
CN101652135B (zh) * 2007-04-02 2012-09-26 帝斯曼知识产权资产管理有限公司 染料木黄酮的用途
WO2009146490A1 (en) 2008-06-03 2009-12-10 John Ray Biffin A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k
US8211947B2 (en) * 2008-01-28 2012-07-03 Guillermo Selman-Housein Sosa Composition and method for treating and preventing musculoskeletal and connective tissue disorders
CN101537170B (zh) * 2008-03-17 2012-05-30 哈药集团制药六厂 一种预防骨质疏松和骨关节病的组合物
CN101574338B (zh) * 2008-05-05 2012-01-11 上海医药工业研究院 一种抑制芳香化酶活性的药物组合物及其应用
TR201004464A2 (tr) * 2010-06-03 2012-11-21 B�Lg�� Mahmut Kemik erimesi için formülasyon.
CN102356877A (zh) * 2011-10-14 2012-02-22 李泼 Cbp养钙冲剂
WO2013089654A1 (en) * 2011-12-16 2013-06-20 Mahmut Bilgic Effervescent formulations comprising genistein
FR3005419B1 (fr) 2013-05-13 2015-09-04 Agronomique Inst Nat Rech Utilisation d'une association de deux composes pour le traitement et/ou la prevention de troubles osseux
JP6468617B2 (ja) * 2014-12-17 2019-02-13 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 甲状腺機能亢進症を減少させるための方法および組成物
CN109527538A (zh) * 2018-11-07 2019-03-29 云南金霓尔生物科技有限公司 一种治疗骨质疏松促进吸收的营养剂及其制备方法
CN112401066B (zh) * 2020-11-18 2022-10-28 乖宝宠物食品集团股份有限公司 一种利于维持骨骼健康的宠物食品
CN112790278B (zh) * 2021-01-22 2022-10-28 乖宝宠物食品集团股份有限公司 一种维持骨骼健康的全价宠物罐头食品
NO349080B1 (en) * 2023-04-26 2025-09-15 Epax Norway As Very long chain fatty acids for use in mineralization

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04253908A (ja) * 1990-12-28 1992-09-09 Nippon Oil & Fats Co Ltd 骨粗鬆症治療薬
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment
GB9217780D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
DE19503190A1 (de) * 1995-02-01 1996-08-08 Dietl Hans Mittel zur Beeinflussung von Störungen der Knochenbildung
JP3250071B2 (ja) * 1997-06-26 2002-01-28 株式会社ホーネンコーポレーション 抗骨粗鬆症組成物
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
US6150399A (en) * 1998-06-30 2000-11-21 Abbott Laboratories Soy-based nutritional products
JP2000191526A (ja) * 1998-12-25 2000-07-11 Marumiya:Kk 骨形成促進及び抗骨粗鬆症組成物
AU4402600A (en) * 1999-05-18 2000-12-05 Rawlings, Anthony V. Fat containing products
FR2817866B1 (fr) * 2000-12-13 2005-01-07 Theramex Procede d'extraction de melanges flavoniques et utilisation des melanges ainsi obtenus en dermocosmetique, en alimentation et en pharmacie

Also Published As

Publication number Publication date
BR0208103A (pt) 2004-03-02
EP1852115A1 (de) 2007-11-07
BRPI0208103B1 (pt) 2018-02-14
JP2004532829A (ja) 2004-10-28
CN1501799A (zh) 2004-06-02
KR20040025906A (ko) 2004-03-26
WO2002074308A1 (en) 2002-09-26
CA2440261C (en) 2014-05-27
EP1854462A1 (de) 2007-11-14
BRPI0208103B8 (pt) 2021-05-25
JP4646491B2 (ja) 2011-03-09
US20040082523A1 (en) 2004-04-29
US7635692B2 (en) 2009-12-22
CN100389765C (zh) 2008-05-28
ES2289097T3 (es) 2008-02-01
KR100875800B1 (ko) 2008-12-24
DE60221367T2 (de) 2008-04-03
MXPA03008137A (es) 2003-12-12
DE60221367D1 (de) 2007-09-06
EP1370257B1 (de) 2007-07-25
EP1370257A1 (de) 2003-12-17
CA2440261A1 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
DE60221367D1 (de) ZUSAMMENSETZUNG ZUR PRÄVENTION VON OSTEOPOROSE bestehend aus EINER KOMBINATION AUS ISOFLAVONEN UND POLYUNGESÄTTIGTEN FETTSÄUREN
WO2003005981A3 (de) Zusammensetzungen auf wachsbasis und verwendung als körperpflegemittel
BR0100765A (pt) Processo para o processamento de composições de borracha contendo ácidos graxos de soja, ácidos graxos de girassol e suas misturas
ATE334978T1 (de) Zusammensetzungen und therapeutische anwendungen von isoflavonen und deren analoga
BR0213546A (pt) Composições ácidas de sanitização e limpeza contendo ácidos carboxìlicos protonados
DE69916414D1 (de) Sojazubereitungen und deren verwendung zur gesundheitsförderung
WO2004010941A3 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
IL126433A0 (en) Compositions comprising isoflavones and their preparation
ATE350072T1 (de) Parfümzusammensetzungen
HUP0401144A2 (hu) Enterális tápszerkészítmények
EA200200880A1 (ru) Агротехническая композиция
DK0950410T3 (da) Konjugeret linolsyresammensætninger
BRPI0407950A (pt) processo para a preparação de uma composição de higiene pessoal
BR9911358A (pt) Derivados de 1,3-oxazolina e 1,3-tiazolina, processos para a sua preparação e sua aplicação como composições praguicidas
ATE381530T1 (de) Cycloalkancarbonsäurederivate als duftstoffe mit moschuscharakter
BR9803251A (pt) Agente de embranquecimento fluorescente
BR0107351A (pt) Composição perfumante sem álcool
BR0116179A (pt) Composição despejável, processo de preparação de uma composição despejável e uso da composição
TNSN03065A1 (en) BIOPESTICIDE COMPOSITIONS
NO994937D0 (no) Krympingsreduserende middel for sementsammensetninger
BRPI0512794A (pt) sistema de pré-mistura anidra, e, método para dispersar pigmento para formar uma pré-mistura
BR0312177A (pt) Composição condicionadora dos cabelos, método de tratamento dos cabelos e uso de uma argila hidrofobicamente modificada
EP1038531A3 (de) Sojabohnen-Isoflavone enthaltende Zusammensetzung und ein Herstellungsverfahren davon
ATE160938T1 (de) Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
DE602005012132D1 (de) Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties